Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Cancer Chemotherapy and Pharmacology|September 29, 2007
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)Fernando Rivera, M Eugenia Vega-Villegas, Marta López-Brea, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2025
Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot studySusana Hernandez, Esther Conde, Marta Alonso, et al.
Anticancer Research|December 7, 2016
Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07Dolores Isla, Enriqueta Felip, Nuria Viñolas, et al.
Cancers|January 21, 2023
A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung CancerMarta Gascón-Ruiz, Ariel Ramírez-Labrada, Rodrigo Lastra, et al.
Lung Cancer (Auckland, N.Z.)|November 16, 2017
nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapyMichael Thomas, David R Spigel, Robert M Jotte, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 studyShirish Gadgeel, Glenwood Goss, Jean-Charles Soria, et al.
Frontiers in Genetics|March 13, 2024
Association between missense variants of uncertain significance in the CHEK2 gene and hereditary breast cancer: a cosegregation and bioinformatics analysisNatalia Alonso, Sebastián Menao, Rodrigo Lastra, et al.
Lung Cancer (Amsterdam, Netherlands)|September 8, 2009
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patientsEnric Carcereny, Jose Luis Ramirez, Maria Sanchez-Ronco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and BiomarkersSolange Peters, Rolf Stahel, Lukas Bubendorf, et al.
Lung Cancer (Amsterdam, Netherlands)|March 8, 2022
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)Benjamin Levy, Fabrice Barlesi, Luis Paz-Ares, et al.
Pageof 15